204 related articles for article (PubMed ID: 10563674)
1. Polymorphisms in tumour necrosis factor and adhesion molecule genes in patients with inflammatory bowel disease: associations with HLA-DR and -DQ alleles and subclinical markers.
Hirv K; Seyfarth M; Uibo R; Kull K; Salupere R; Latza U; Rink L
Scand J Gastroenterol; 1999 Oct; 34(10):1025-32. PubMed ID: 10563674
[TBL] [Abstract][Full Text] [Related]
2. Ulcerative colitis: a genetically heterogeneous disorder defined by genetic (HLA class II) and subclinical (antineutrophil cytoplasmic antibodies) markers.
Yang H; Rotter JI; Toyoda H; Landers C; Tyran D; McElree CK; Targan SR
J Clin Invest; 1993 Aug; 92(2):1080-4. PubMed ID: 8349790
[TBL] [Abstract][Full Text] [Related]
3. Inflammatory bowel disease: susceptibility and disease heterogeneity revealed by human leukocyte antigen genotyping.
Bouzid D; Kammoun A; Amouri A; Mahfoudh N; Haddouk S; Tahri N; Makni H; Masmoudi H
Genet Test Mol Biomarkers; 2012 Jun; 16(6):482-7. PubMed ID: 22224635
[TBL] [Abstract][Full Text] [Related]
4. Are HLA-DR or TAP genes genetic markers of severity in ulcerative colitis?
Heresbach D; Alizadeh M; Reumaux D; Colombel JF; Delamaire M; Danze PM; Gosselin M; Genetet B; Bretagne JF; Semana G
J Autoimmun; 1996 Dec; 9(6):777-84. PubMed ID: 9115580
[TBL] [Abstract][Full Text] [Related]
5. Contribution of genes of the major histocompatibility complex to susceptibility and disease phenotype in inflammatory bowel disease.
Satsangi J; Welsh KI; Bunce M; Julier C; Farrant JM; Bell JI; Jewell DP
Lancet; 1996 May; 347(9010):1212-7. PubMed ID: 8622450
[TBL] [Abstract][Full Text] [Related]
6. Polymorphism in ICAM-1, PECAM-1, E-selectin, and L-selectin genes in Tunisian patients with inflammatory bowel disease.
Khazen D; Jendoubi-Ayed S; Aleya WB; Sfar I; Mouelhi L; Matri S; Najjar T; Filali A; Gorgi Y; Abdallah TB; Ayed K
Eur J Gastroenterol Hepatol; 2009 Feb; 21(2):167-75. PubMed ID: 19212205
[TBL] [Abstract][Full Text] [Related]
7. Analysis of ICAM-1 gene polymorphism in immunologic subsets of inflammatory bowel disease.
Yang H
Exp Clin Immunogenet; 1997; 14(3):214-25. PubMed ID: 9493790
[TBL] [Abstract][Full Text] [Related]
8. Distribution of four polymorphisms in the tumour necrosis factor (TNF) genes in patients with inflammatory bowel disease (IBD).
Bouma G; Xia B; Crusius JB; Bioque G; Koutroubakis I; Von Blomberg BM; Meuwissen SG; Peña AS
Clin Exp Immunol; 1996 Mar; 103(3):391-6. PubMed ID: 8608636
[TBL] [Abstract][Full Text] [Related]
9. Association of the HLA-DRB1*0701 allele with perinuclear anti-neutrophil cytoplasmatic antibodies in Mexican patients with severe ulcerative colitis.
Yamamoto-Furusho JK; Uscanga-Domínguez L; Lopez-Martinez A; Granados J
World J Gastroenterol; 2006 Mar; 12(10):1617-20. PubMed ID: 16570357
[TBL] [Abstract][Full Text] [Related]
10. Association of HLA class-II genes and anti-neutrophil cytoplasmic antibodies in Chinese patients with inflammatory bowel disease.
Lee YT; Sung JJ; Poon P; Lai KN; Li PK
Scand J Gastroenterol; 1998 Jun; 33(6):623-7. PubMed ID: 9669635
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms in the promoter region of tumor necrosis factor alpha (TNF-alpha) and the HLA-DRB1 locus in Mexican mestizo patients with ulcerative colitis.
Yamamoto-Furusho JK; Uscanga LF; Vargas-Alarcón G; Rodríguez-Pérez JM; Zuñiga J; Granados J
Immunol Lett; 2004 Aug; 95(1):31-5. PubMed ID: 15325795
[TBL] [Abstract][Full Text] [Related]
12. Association of IL23R, TNFRSF1A, and HLA-DRB1*0103 allele variants with inflammatory bowel disease phenotypes in the Finnish population.
Lappalainen M; Halme L; Turunen U; Saavalainen P; Einarsdottir E; Färkkilä M; Kontula K; Paavola-Sakki P
Inflamm Bowel Dis; 2008 Aug; 14(8):1118-24. PubMed ID: 18338763
[TBL] [Abstract][Full Text] [Related]
13. Association of HLA-DRB1 alleles and anti-neutrophil cytoplasmic antibodies in Han and Uyghur patients with ulcerative colitis in China.
Gao F; Aheman A; Lu JJ; Abuduhadeer M; Li YX; Kuerbanjiang A
J Dig Dis; 2014 Jun; 15(6):299-305. PubMed ID: 24597629
[TBL] [Abstract][Full Text] [Related]
14. Genetic heterogeneity within ulcerative colitis determined by an interleukin-1 receptor antagonist gene polymorphism and antineutrophil cytoplasmic antibodies.
Papo M; Quer JC; Gutierrez C; Broch M; Casellas F; Pastor RM; Olona M; Richart C
Eur J Gastroenterol Hepatol; 1999 Apr; 11(4):413-20. PubMed ID: 10321759
[TBL] [Abstract][Full Text] [Related]
15. Intercellular adhesion molecule 1 gene associations with immunologic subsets of inflammatory bowel disease.
Yang H; Vora DK; Targan SR; Toyoda H; Beaudet AL; Rotter JI
Gastroenterology; 1995 Aug; 109(2):440-8. PubMed ID: 7615193
[TBL] [Abstract][Full Text] [Related]
16. Lack of association between HLA-DRB1 alleles of the major histocompatibility complex and p-ANCA status or clinical characteristics in patients with ulcerative colitis.
Folwaczny C; Zahn R; Brünnler G; Albert E; Koenig A; Noehl N; Loeschke K; Fricke H
Z Gastroenterol; 1999 Feb; 37(2):133-40. PubMed ID: 10190246
[TBL] [Abstract][Full Text] [Related]
17. Immunogenetic risk factors for anti-neutrophil cytoplasmic antibody (ANCA)-associated systemic vasculitis.
Gencik M; Borgmann S; Zahn R; Albert E; Sitter T; Epplen JT; Fricke H
Clin Exp Immunol; 1999 Aug; 117(2):412-7. PubMed ID: 10444278
[TBL] [Abstract][Full Text] [Related]
18. The distribution of HLA-DRB alleles in ulcerative colitis patients in Turkey.
Uyar FA; Imeryüz N; Saruhan-Direskeneli G; Ceken H; Ozdoğan O; Sahin S; Tözün N
Eur J Immunogenet; 1998 Aug; 25(4):293-6. PubMed ID: 9777329
[TBL] [Abstract][Full Text] [Related]
19. HLA class II haplotype associations with inflammatory bowel disease in Jewish (Ashkenazi) and non-Jewish caucasian populations.
Trachtenberg EA; Yang H; Hayes E; Vinson M; Lin C; Targan SR; Tyan D; Erlich H; Rotter JI
Hum Immunol; 2000 Mar; 61(3):326-33. PubMed ID: 10689124
[TBL] [Abstract][Full Text] [Related]
20. Evidence for genetic heterogeneity in inflammatory bowel disease (IBD); HLA genes in the predisposition to suffer from ulcerative colitis (UC) and Crohn's disease (CD).
Bouma G; Oudkerk Pool M; Crusius JB; Schreuder GM; Hellemans HP; Meijer BU; Kostense PJ; Giphart MJ; Meuwissen SG; Peña AS
Clin Exp Immunol; 1997 Jul; 109(1):175-9. PubMed ID: 9218841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
